Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

A 5-year follow-up of those randomized to receive or not receive radioiodine after thyroidectomy showed nearly the same low ...

A new report from the American Cancer Society has uncovered a shocking and deeply concerning trend: young women under 50 are ...

Watch how this young cancer fighter has been grappling with the life-altering impact of a rare and incurable form of thyroid cancer. Saskia Clark tells how she had to reshape her life after she found ...

No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...

Researchers conducted a randomized controlled trial to assess the need for postoperative radioiodine therapy among patients with low-risk thyroid cancer.